Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Waskyrafda.gov · Low evidenceWASKYRA (etuvetidigene autotemcel) is a gene therapy for pediatric patients aged 6 months and older and adults with Wiskott-Aldrich Syndrome who have a mutation in the WAS gene. It is indicated for patients for whom hematopoietic stem cell transplantation is appropriate but no suitable HLA-matched related stem cell donor is available.
WaskyraParse Score
Sources
en.wikipedia.org shapes more of what AI says about Waskyra than any other source, at 100% of its citations.